NZ333652A - Inhibition of human rotavirus infection using kappa-casein - Google Patents

Inhibition of human rotavirus infection using kappa-casein

Info

Publication number
NZ333652A
NZ333652A NZ333652A NZ33365299A NZ333652A NZ 333652 A NZ333652 A NZ 333652A NZ 333652 A NZ333652 A NZ 333652A NZ 33365299 A NZ33365299 A NZ 33365299A NZ 333652 A NZ333652 A NZ 333652A
Authority
NZ
New Zealand
Prior art keywords
casein
kappa
inhibition
human rotavirus
rotavirus infection
Prior art date
Application number
NZ333652A
Inventor
Pradip Mukerji
Pedro Antonio Prieto
Amanda Eug-Yeong Seo
Jeffrey Harris Baxter
Richard Dale Cummings
Original Assignee
Abbott Lab
Univ Oklahoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/308,883 external-priority patent/US5576300A/en
Application filed by Abbott Lab, Univ Oklahoma filed Critical Abbott Lab
Publication of NZ333652A publication Critical patent/NZ333652A/en

Links

Abstract

This use of native or recombinant unhydrolyzed human or bovine k-casein (kappa-casein) is in medicaments for treating or retarding the onset of human rotavirus.
NZ333652A 1994-09-16 1999-01-06 Inhibition of human rotavirus infection using kappa-casein NZ333652A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30888294A 1994-09-16 1994-09-16
US08/308,883 US5576300A (en) 1994-09-16 1994-09-16 Method for inhibition of human rotavirus infection
NZ28559399 1999-01-06

Publications (1)

Publication Number Publication Date
NZ333652A true NZ333652A (en) 2000-07-28

Family

ID=27353773

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ333652A NZ333652A (en) 1994-09-16 1999-01-06 Inhibition of human rotavirus infection using kappa-casein

Country Status (1)

Country Link
NZ (1) NZ333652A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114837B2 (en) 2005-09-30 2012-02-14 Morinaga Milk Industry Co., Ltd. Method for inhibiting postprandial rise in blood glucose by administering κ-casein

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114837B2 (en) 2005-09-30 2012-02-14 Morinaga Milk Industry Co., Ltd. Method for inhibiting postprandial rise in blood glucose by administering κ-casein
US8367608B2 (en) 2005-09-30 2013-02-05 Morinaga Milk Industry Co., Ltd. Method for promoting secretion of glucagon-like peptide-1 by administering κ-casein

Similar Documents

Publication Publication Date Title
AU594488B2 (en) Agents for the treatment of arthroses
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
AU1049788A (en) Methods and peptides for the treatment of non-ige-mediated diseases
GR880300077T1 (en) Galanthamine or analogues thereof for treating alzheimer's disease
OA08729A (en) Agents for prophylaxis and therapy of retroviral infections.
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
EP0906310A4 (en) OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE -g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
IL81964A (en) Aprotinin and aprotinin homologues in which the amino acids in positions 15 and 52 have benn substituted
ZA889033B (en) Vectors and compounds for direct expression of activated human protein c.
GB2229075B (en) Equine limb bandage
IL99778A0 (en) Compositions for the treatment of cell proliferation disorders
EP0350738A3 (en) (s)-emopamil for use in the treatment of migraine
GR3036775T3 (en) Macroscopically oriented cell adhesion protein for wound treatment.
ZA879403B (en) Primary biliary cirrhosis autoantigen
AU3709289A (en) Strontium salt
NZ333652A (en) Inhibition of human rotavirus infection using kappa-casein
DE59711240D1 (en) USE OF FLUPIRTIN FOR THE THERAPY AND PROPHYLAXIS OF MYOKARDINE FARCT, SHOCKNIERE AND SHOCKLUNG
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
HK88396A (en) 24r-scymnol and preparation and use thereof
SE8501202D0 (en) HUMAN INTESTINAL HORMONE AND ITS USE
GR3005231T3 (en)
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
ES8602799A1 (en) Hydantoin therapeutic agents.
AU3575189A (en) Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
JO1493B1 (en) Pharmaceutical compositions for the treatment of high blood pressure

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)